NASDAQ
NOVN

Novan Inc

Pharmaceuticals
Healthcare

Prices are adjusted according to historical splits.

Novan Inc Stock Price

Vitals

Today's Low:
$0.02
Today's High:
$0.0275
Open Price:
$0.02
52W Low:
$0.0191
52W High:
$2.45
Prev. Close:
$0.02
Volume:
78866

Company Statistics

Market Cap.:
$2.64 million
Book Value:
-0.101
Revenue TTM:
$24.92 million
Operating Margin TTM:
-159.12%
Gross Profit TTM:
$313000
Profit Margin:
-128.61%
Return on Assets TTM:
-25.84%
Return on Equity TTM:
-2098.89%

Company Profile

Novan Inc had its IPO on 2016-09-21 under the ticker symbol NOVN.

The company operates in the Healthcare sector and Pharmaceuticals industry. Novan Inc has a staff strength of 90 employees.

Stock update

Shares of Novan Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.03, and closed at $0.02.

This is a +19.5% increase from the previous day's closing price.

A total volume of 78,866 shares were traded at the close of the day’s session.

In the last one week, shares of Novan Inc have slipped by -46.89%.

Novan Inc's Key Ratios

Novan Inc has a market cap of $2.64 million, indicating a price to book ratio of 5.1023 and a price to sales ratio of 2.2951.

In the last 12-months Novan Inc’s revenue was $24.92 million with a gross profit of $313000 and an EBITDA of $-36206000. The EBITDA ratio measures Novan Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Novan Inc’s operating margin was -159.12% while its return on assets stood at -25.84% with a return of equity of -2098.89%.

In Q1, Novan Inc’s quarterly earnings growth was a negative -61.5% while revenue growth was a positive 64.2%.

Novan Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.84 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Novan Inc’s profitability.

Novan Inc stock is trading at a EV to sales ratio of 1.7064 and a EV to EBITDA ratio of -0.7115. Its price to sales ratio in the trailing 12-months stood at 2.2951.

Novan Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$79.79 million
Total Liabilities
$43.91 million
Operating Cash Flow
$-23000.00
Capital Expenditure
$23000
Dividend Payout Ratio
0%

Novan Inc ended 2024 with $79.79 million in total assets and $0 in total liabilities. Its intangible assets were valued at $79.79 million while shareholder equity stood at $-2828000.00.

Novan Inc ended 2024 with $0 in deferred long-term liabilities, $43.91 million in other current liabilities, 3000.00 in common stock, $-324399000.00 in retained earnings and $4.06 million in goodwill. Its cash balance stood at $12.54 million and cash and short-term investments were $12.54 million. The company’s total short-term debt was $465,000 while long-term debt stood at $0.

Novan Inc’s total current assets stands at $32.69 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $13.84 million compared to accounts payable of $14.32 million and inventory worth $1.12 million.

In 2024, Novan Inc's operating cash flow was $-23000.00 while its capital expenditure stood at $23000.

Comparatively, Novan Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.02
52-Week High
$2.45
52-Week Low
$0.0191
Analyst Target Price
$10.8

Novan Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $2.45 and a 52-week low of $2.45. Analysts tracking the stock have a 12-month average target price of $10.8.

Its 50-day moving average was $0.16 and 200-day moving average was $0.96 The short ratio stood at 0.71 indicating a short percent outstanding of 0%.

Around 86.9% of the company’s stock are held by insiders while 1492.7% are held by institutions.

Frequently Asked Questions About Novan Inc

The stock symbol (also called stock or share ticker) of Novan Inc is NOVN

The IPO of Novan Inc took place on 2016-09-21

Similar Industry Stocks (Pharmaceuticals)

Last Price
Chg
Chg%
$17.69
-0.31
-1.72%
$11.27
-0.38
-3.26%
$1075.35
-77.25
-6.7%
ICON PLC (ICLR)
$257.28
1.82
+0.71%
$292.85
-4.65
-1.56%
$5
-0.02
-0.4%
$185.3
-3.7
-1.96%
$0.83
-0.01
-1.19%
CNI RESEARCH LTD. (CNIRESLTD)
$2.14
-0.03
-1.38%
$0.03
0.01
+22.71%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Novan, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete’s foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Durham, North Carolina. On July 17, 2023, Novan, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Address

4020 Stirrup Creek Drive, Durham, NC, United States, 27703